These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 30253186)

  • 1. Phase separation of supersaturated solution created from amorphous solid dispersions: Relevance to oral absorption.
    Kawakami K; Sato K; Fukushima M; Miyazaki A; Yamamura Y; Sakuma S
    Eur J Pharm Biopharm; 2018 Nov; 132():146-156. PubMed ID: 30253186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymeric Precipitation Inhibitors Promote Fenofibrate Supersaturation and Enhance Drug Absorption from a Type IV Lipid-Based Formulation.
    Suys EJA; Chalmers DK; Pouton CW; Porter CJH
    Mol Pharm; 2018 Jun; 15(6):2355-2371. PubMed ID: 29659287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.
    Ashwathy P; Anto AT; Sudheesh MS
    Drug Dev Ind Pharm; 2021 Jan; 47(1):1-11. PubMed ID: 33494623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supersaturation and crystallization: non-equilibrium dynamics of amorphous solid dispersions for oral drug delivery.
    Kawakami K
    Expert Opin Drug Deliv; 2017 Jun; 14(6):735-743. PubMed ID: 27598556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissolution of Danazol Amorphous Solid Dispersions: Supersaturation and Phase Behavior as a Function of Drug Loading and Polymer Type.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Mol Pharm; 2016 Jan; 13(1):223-31. PubMed ID: 26618718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissolution and Solubility Enhancement of the Highly Lipophilic Drug Phenytoin via Interaction with Poly(N-isopropylacrylamide-co-vinylpyrrolidone) Excipients.
    Widanapathirana L; Tale S; Reineke TM
    Mol Pharm; 2015 Jul; 12(7):2537-43. PubMed ID: 26046484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of Liquid-Liquid Phase Separation of Supersaturated Solution in Oral Absorption of Albendazole from Amorphous Solid Dispersions.
    Suzuki K; Kawakami K; Fukiage M; Oikawa M; Nishida Y; Matsuda M; Fujita T
    Pharmaceutics; 2021 Feb; 13(2):. PubMed ID: 33562770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution Performance of High Drug Loading Celecoxib Amorphous Solid Dispersions Formulated with Polymer Combinations.
    Xie T; Taylor LS
    Pharm Res; 2016 Mar; 33(3):739-50. PubMed ID: 26563205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of amorphous phase separation and crystallization on the in vitro and in vivo performance of an amorphous solid dispersion.
    Knopp MM; Wendelboe J; Holm R; Rades T
    Eur J Pharm Biopharm; 2018 Sep; 130():290-295. PubMed ID: 30064702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glass-liquid phase separation in highly supersaturated aqueous solutions of telaprevir.
    Mosquera-Giraldo LI; Taylor LS
    Mol Pharm; 2015 Feb; 12(2):496-503. PubMed ID: 25541813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solubility advantage from amorphous etoricoxib solid dispersions.
    Dani P; Puri V; Bansal AK
    Drug Dev Ind Pharm; 2014 Jan; 40(1):92-101. PubMed ID: 23301771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leaching of Lopinavir Amorphous Solid Dispersions in Acidic Media.
    Li N; Ormes JD; Taylor LS
    Pharm Res; 2016 Jul; 33(7):1723-35. PubMed ID: 27026009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogenated phospholipid, a promising excipient in amorphous solid dispersions of fenofibrate for oral delivery: Preparation and in-vitro biopharmaceutical characterization.
    Czajkowski M; Jacobsen AC; Bauer-Brandl A; Brandl M; Skupin-Mrugalska P
    Int J Pharm; 2023 Sep; 644():123294. PubMed ID: 37544387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.
    Jia Z; Lin P; Xiang Y; Wang X; Wang J; Zhang X; Zhang Q
    Eur J Pharm Biopharm; 2011 Sep; 79(1):126-34. PubMed ID: 21658449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining crystalline and polymeric excipients in API solid dispersions - Opportunity or risk?
    Veith H; Wiechert F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2021 Jan; 158():323-335. PubMed ID: 33296719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of polymer excipients on the dissolution and recrystallization behavior of ketoconazole: Application, variation and practical aspects of a pH shift method.
    Ullrich A; Schiffter HA
    Eur J Pharm Biopharm; 2018 Dec; 133():20-30. PubMed ID: 30261267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.
    Jackson MJ; Kestur US; Hussain MA; Taylor LS
    Pharm Res; 2016 May; 33(5):1276-88. PubMed ID: 26892947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the generation and maintenance of supersaturation during the dissolution of amorphous solid dispersions using modulated DSC and
    Baghel S; Cathcart H; O'Reilly NJ
    Int J Pharm; 2018 Jan; 536(1):414-425. PubMed ID: 29183857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutual Impact of Phase Separation/Crystallization and Water Sorption in Amorphous Solid Dispersions.
    Luebbert C; Wessner M; Sadowski G
    Mol Pharm; 2018 Feb; 15(2):669-678. PubMed ID: 29309155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploiting the Phenomenon of Liquid-Liquid Phase Separation for Enhanced and Sustained Membrane Transport of a Poorly Water-Soluble Drug.
    Indulkar AS; Gao Y; Raina SA; Zhang GG; Taylor LS
    Mol Pharm; 2016 Jun; 13(6):2059-69. PubMed ID: 27138900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.